Category: Medical

  • Hospitals in the US will spend USD 443B more on free treatment

    Hospitals in the US will spend USD 443B more on free treatment

    Hospital trade groups widely panned the Senate Republican tax bill, and a new analysis suggests that it would see health systems spending billions more on patients without Medicaid coverage.

    Hospitals would see their costs for uncompensated care rise by $443 billion over the next ten years under the Senate proposal, according to an analysis released Friday by America’s Essential Hospitals.

    In 2034, hospitals would see their costs for uncompensated care rise by at least $84 billion in the Senate GOP plan, or twice as much as the $41.7 projected in the House Republican plan, the report estimates.

    America’s Essential Hospitals, which represents 350 safety net hospitals and health systems, says those providers would be hit especially hard under the Senate tax plan.

    Safety net hospitals, who care for greater populations of Medicaid patients, would see a disproportionate hit under the Senate plan, which critics say would result in millions of Americans losing Medicaid coverage. The Senate plan would place more restrictions on how states finance Medicaid plans and would also impose more strict work requirements, hospital groups say.

    Essential hospitals would be saddled with 25% of the higher costs of uncompensated care, even though those safety net hospitals represent only 5% of the nation’s hospitals, the new report said. The report estimates that essential hospitals would see $20.8 billion in reduced aid in 2034, and $110 billion between 2025 and 2034.

    “Cuts of this magnitude would disproportionately harm essential hospitals and the communities that they serve,” the report states.

    Hospitals and health systems had plenty of objections to the House tax plan, but they say provisions in the Senate plan would put more restrictions on how states finance Medicaid programs. The House bill would freeze state directed payments at current levels, but the Senate plan would force 34 states to reduce payments, according to projections from America’s Essential Hospitals.

    Bruce Siegel, MD, president and CEO of America’s Essential Hospitals, said in a statement earlier this week, “The draconian Medicaid cuts contained in the Senate bill would devastate health care access for millions of Americans and hollow out the vital role essential hospitals play in their communities.”

    While many of America’s Essential Hospitals are based in cities, two-thirds of the group’s members operate hospitals in rural areas. Hospitals and even some Republican lawmakers have said some of the congressional proposals could hurt rural hospitals and could potentially force some of them to close.

    The Catholic Health Association of the United States has warned that the Senate plan would lead to millions of people losing Medicaid coverage, and that some hospitals would have to consider dropping services or even shutting down.

    Laura Kaiser, president and CEO of SSM Health, said in a news conference with Catholic hospital leaders Tuesday that some rural hospitals may be among those in the most danger. She said rural hospitals are already “facing enormous, enormous challenges, staffing shortages, rising costs, and in many cases, razor thin margins or no margin.”

    “For many, Medicaid is the primary payer,” Kaiser said. “When that support is weakened, the entire system teeters. When rural hospitals close, entire communities lose lifelines, not just for chronic care, but for emergencies, childbirth, trauma, everything in between.”

    Even under the House package, as many as 1.8 million Americans living in rural communities would lose coverage by 2034, according to an analysis released Monday by the American Hospital Association. Rural hospitals would lose $50.4 billion in federal Medicaid funding over the next decade, under provisions in the House plan, the association said.

    Hospitals have said if millions of people lose coverage under Medicaid, then many of those Americans would likely end up coming to emergency departments for their care. And hospitals say the prospect of treating more people with no ability to pay will pose more hardships, with many health systems losing money or barely breaking even.

    Hospital leaders also say many of those showing up without coverage will likely have more advanced diseases, requiring longer and more expensive stays.

    The Congressional Budget Office, a nonpartisan research arm of Congress, has estimated that 10.9 million Americans would lose coverage under the House bill, the Associated Press reported. Chief Healthcare Executive

  • As per the Center, COVID-19 spread across India

    As per the Center, COVID-19 spread across India

    Covid-19 has become endemic in India, top scientists at the Department of Biotechnology (DBT) monitoring the virus have said, ruling out the risk of any severe fresh outbreak. The current situation, they noted, is marked by small, isolated episodes rather than large waves of infections.

    This assessment is reflected in the steadily declining number of active cases. India’s active caseload dropped to 5,012 on Sunday, down from 5,976 on Friday, according to official data. Two new deaths were recorded in the last 24 hours, taking the total fatalities this year to 112.

    Scientists attribute the decline to high population immunity and the continuing mildness of the virus. The current spread is largely driven by Omicron sub-variants NB.1.8.1 and LF.7, which have so far remained less virulent.

    “When transmission efficiency increases, the peak comes faster and the decline is also faster,” said Dr Raman Gangakhedkar, national chair at the Indian Council of Medical Research (ICMR) and former head scientist at the agency. “Covid-19 has become endemic in India. The concerning part is that we don’t want new infections, but the good news is that new variants over the last three years have remained mild or milder.”

    He also noted that many infections now go undetected but still contribute to building antibody responses in the population, a natural form of immunization that limits severe illness.

    The testing levels have declined, and comprehensive data on current infections remains limited.

    “Presently, there is no very good record of the number of tests being done, and it needs to be done scientifically. But there are no significant adverse clinical symptoms to be concerned about,” one senior DBT scientist said.

    Dr Rajeev Jayadevan, public health expert and past president of the Indian Medical Association (IMA), Cochin, said that Covid-19 is now behaving like a cyclical disease, with temporary immunity leading to periodic rises in cases. “As the level of immunity in the population drops, the virus is able to infect more people and cases will naturally rise. However, due to past vaccination and exposure to the virus earlier, immune memory protects against severe disease and death,” he said. Vulnerable individuals, he added, should remain cautious, especially during periods of surge.

    Jayadevan also pointed out that SARS-CoV-2 continues to evolve in response to the human immune system, leading to recurring infection cycles roughly every 6 to 12 months. “The reported number of cases is always an underestimate because of limited testing,” he said. Influenza, which is also circulating, remains a significant contributor to disease burden, he added.

    Earlier, Mint reported that a spike in cases during April was driven by the JN.1.16 sub-variant of Omicron. In May, most cases were linked to recombinant sub-lineages such as LF.7 and LP.8.1.2. As per government guidelines, all hospitalized Severe Acute Respiratory Illness (SARI) patients and 5% of Influenza Like Illness (ILI) cases continue to be tested for Covid-19. Positive SARI samples are routinely sent for genome sequencing.

    The health ministry reported 1,197 recoveries in the past 24 hours, bringing total recoveries this year to 19,435. Authorities continue to advise precautions, including avoiding crowded places when unwell and following Covid-appropriate behaviour.

    “In hospitals too, patient load has come down and most cases are now manageable at home,” said Dr Vikas Maurya, head of the respiratory department at Fortis Hospital, Shalimar Bagh. LiveMint

  • MoHFW advises liver & heart transplants to AB.-PMJAY

    MoHFW advises liver & heart transplants to AB.-PMJAY

    The union health ministry has called for including liver and heart transplants under the government’s flagship health insurance scheme, the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY).

    This assumes importance given that health insurance schemes in the country cover life and disability, but not organ donation.

    The recommendation comes in a report, titled the National Review Meeting on Organ Transplantation Activities in Government Hospitals, prepared by the National Organ Tissue Transplant Organization (NOTTO), a top body which manages organ transplantation, under the health ministry.

    The call for expanding insurance coverage comes in the backdrop of the low number of organ transplants performed in India. Mint has seen a copy of the report, which has been submitted to health ministry.

    AB PM-JAY is the world’s largest health insurance scheme, providing health cover of ₹5 lakh per family per year. Notably, the scheme’s ambit has been expanded to include free treatment benefits of up to ₹5 lakh per year to senior citizens aged 70 years and above.

    Earlier this month, a nationwide review meeting was conducted on organ transplants in government hospitals by a group of top government experts to identify bottlenecks in the system and formulate a roadmap for improvement.

    The report underlined that government institutions have inadequate capacities and that new centres are required to be established and made functional. It emphasized the need for a multi-pronged strategy involving policy changes, financial investment, and capacity building to bridge the demand-supply gap in organ transplantation.

    The report highlighted a huge gap between demand and supply: while India requires at least 100,000 kidney transplants per year, only 13,476 were performed in 2024 across both government and private centers.

    “These recommendations aim to strengthen India’s organ transplantation capabilities and make life-saving procedures more accessible to those in need. During the nationwide assessment of the government hospitals, we identified their challenges and suggested measures to improve their capabilities in terms of infrastructure, finance, manpower etc. We have submitted our report to the health ministry and now the ministry will take action on these recommendations,” said Dr. Anil Kumar, director, NOTTO.

    One of the key recommendations is to include comprehensive inclusion of liver and heart transplantation in national health schemes like PMJAY, he added.

    “Some states like Maharashtra and Delhi have expanded their coverage under the PM-JAY scheme. So, the recommendation of the report to include liver and heart transplantation under PM-JAY may be considered to accelerate organ transplantation in the government institutions,” he said.

    Dr Anup Kumar, head of kidney transplant and urology department at Safdarjung Hospital, New Delhi, said, “ It is a welcome move. PMJAY offers coverage of up to ₹5 lakh, but these are very expensive procedures require ₹20-25 lakh in the private sector. However, in government institutions these transplants can be done in ₹10 lakh. So, to cover these two transplants, the government has to also consider increasing the coverage plan of PMJAY from ₹5 lakh to at least ₹10 lakh.”

    Further, to bridge the critical demand-supply gap, the expert group has put forth several key recommendations, which include financial incentives for transplant teams, enhanced funding for infrastructure development, establishment of dedicated transplant centres and robust training programmes for medical personnel and transplant coordinators.

    “We have tried to understand why government institutions are not able to do the maximum number of organ transplants and what are the solutions. Do we require to build new centres or strengthen the existing capacities. Some government centres like Institute of Kidney Diseases and Research Centre (IKDRC) Ahmedabad conducted a total of 508 organ transplants in the last year, including 195 cadaveric transplants, PGIMER Chandigarh performed 320 organ transplants including 55 cadaveric transplants,” Dr. Kumar said.

    However, the report revealed that government institutions like GB Pant Hospital, New Delhi, despite having the physical infrastructure and licence, did not perform any organ transplants. LiveMint

  • Music therapy serves in hospitals to ease anxiety enhance surgical procedures

    Music therapy serves in hospitals to ease anxiety enhance surgical procedures

    Sometimes, treatment begins with a simple question: “What song do you love?” Once just background comfort, music is now being embraced as a clinical aid in surgical and medical care, thanks to its proven psychological and physiological benefits.

    “We sometimes ask patients what their favourite songs are,” said Dr Renu Singh, a gynaecological surgeon at Queen Mary Hospital in Lucknow. “Most of our procedures are done under regional anaesthesia, where patients remain conscious. This awareness can heighten anxiety—they worry about how long the surgery will take, what the outcome will be, and even what the doctors are discussing.”

    To counter this, Dr Singh and her team curate customised playlists based on patient preferences—ranging from bhajans and soft instrumental music to upbeat tracks, including Bollywood numbers. “It’s amazing to see how something as simple as familiar music can calm them. They often say the surgery felt shorter, and their stress visibly reduces.”

    Surgeries can last anywhere from 30 minutes to four hours. During this time, the presence of machines, beeping monitors, and clinical chatter can overwhelm patients. “Music acts as a mind-diverting technique,” Dr Singh added. “It drowns out the intimidating noise of the operation theatre and allows patients to focus on something comforting.”

    Dr Ritu Verma, an anaesthesia expert at Queen Mary Hospital, noted, “Many patients arrive extremely anxious. For them, we offer music therapy — sometimes through overhead speakers, and other times via headphones. It’s not just feel-good therapy; there are real clinical benefits. Despite the promising results, this tool remains underutilised.”

    “It also helps in faster post-op recovery and reduces the chances of nausea when patients are coming out of anaesthesia,” Dr Verma explained.

    At Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), music is being used during complex procedures such as kidney transplants. “We’ve noticed that patients who listen to music beforehand are more relaxed—their blood pressure and heart rate are usually lower,” said Dr Narayan Prasad, head of nephrology at SGPGIMS.

    The science behind this isn’t new—but it’s only now finding widespread application in Indian hospitals. “Music works in subtle but powerful ways,” Dr Prasad said. “It’s non-pharmacological, safe, cost-effective, and most importantly, patients genuinely enjoy it.”

    Music is increasingly being used as a clinical tool to support the heart, calm the mind, and enhance recovery in patients with cardiovascular conditions.

    “Music helps the heart — quite literally,” said Dr Aditya Kapoor, head of cardiology at SGPGIMS. “It helps regulate the heartbeat, eases stress, and motivates patients during recovery. It’s one of the safest non-drug therapies we have.”

    “More and more cardiologists are using music therapy to stabilise patients. The evidence so far is very encouraging,” Dr Kapoor added. “In cardiac rehabilitation, we use music therapy and have observed that it reduces the release of stress hormones and helps stabilise heart rate, blood pressure, and other parameters.”

    Sleep, pain and psychological well-being
    Doctors report that music therapy contributes to better sleep quality — an essential element of cardiac rehabilitation. Post-operative patients also report lower pain perception when exposed to calming music.

    In cardiac rehab, music isn’t just a mood lifter — it becomes a motivator. “Patients undergoing supervised exercise programs perform better and with greater enthusiasm when music is played,” said Dr Kapoor. Hindustan Times

  • ₹136cr multi-specialty hospital in TN’s is almost finished

    ₹136cr multi-specialty hospital in TN’s is almost finished

    The construction of a multi-specialty hospital at an outlay of ₹136 crore on the premises of Thoothukudi Government Medical College and Hospital (TKGMCH) is nearing completion, marking a significant milestone in the region’s healthcare department. The infrastructure works of the facility are currently in progress, bringing the project closer to full-scale operation.

    The 650 bedded facility is being developed on a 4.1 acre site, and will comprise seven floors. Of the total cost, ₹118.35 crore has been allocated for civil and electrical works, ₹16 crore for medical equipment and ₹2 crore for furniture. Once completed, the hospital is expected to provide specialised and comprehensive care under one roof.

    The hospital has been designed to cater to a wide range of facilities. The ground floor of the hospital will house the radio diagnosis unit, radiation oncology, central lab, central sterile supply department and pharmacy. The first floor will be dedicated to cardiology and cardio thoracic surgery, including a cath ICU. The second floor will accommodate neurology and neurosurgery departments, while the third floor will be allotted to nephrology and urology. The fourth floor will house departments of medical and surgical gastroenterology and the fifth floor will be for medical and surgical oncology. The sixth floor will cater to plastic surgery and burn injuries and the seventh floor will feature operation theatres and post operative wards.

    To ensure smooth and efficient functioning the hospital administration has proposed for 52 doctors, 150 staff nurses, 36 ministerial staff, 110 para medical staff and 70 sanitary workers. As the final stages of infrastructure work progress, installation of medical equipment will begin following necessary government approvals.

    Speaking about the upcoming medical facility in Thoothukudi, Silas Jeyamani, Resident Medical Officer of TKGMCH said that the new hospital would significantly improve the functioning of each department, many of which currently operate in limited spaces. He added that departments such as medical oncology, surgical oncology and nephrology have so far been functioning as a single man department and the new facility will allow for the appointment of additional doctors in every department. The Hindu

  • Dialysis gear sales in India anticipate to rise at a 2% CAGR

    Dialysis gear sales in India anticipate to rise at a 2% CAGR

    India’s dialysis machines market is projected to expand at a compound annual growth rate of 2% through 2036, according to GlobalData.

    The sector’s growth is attributed to the urgent demand for advanced dialysis treatment amidst an increase in chronic kidney disease cases, particularly in semi-urban and rural areas.

    “The emergence of artificial intelligence (AI)-driven and cloud-connected technologies is enabling earlier interventions and personalised care, especially in resource-scarce regions,” said Nidhi Bharti, Medical Devices Analyst at GlobalData.

    The country accounted for around 3% of the Asia-Pacific market in 2024. Healthcare Asia Magazine

  • India’s COVID-19 case drop: Experts’ views on risks rising signs, and safety

    India’s COVID-19 case drop: Experts’ views on risks rising signs, and safety

    India, among many other countries across the globe, witnessed a sudden rise in COVID-19 cases. Triggered by four new Omicron sub-variants—LF.7, XFG, JN.1.16, and NB.1.8.1—several fresh cases emerged across India until Friday. On 20 June, positive cases witnessed a gradual decline. While the daily case numbers are dropping and the overall severity has remained low, health experts caution that the situation is far from over.

    Decline in Covid cases, how safe is India?
    India’s active COVID-19 caseload dropped to 5,976 on Friday, marking a decline from 6,483 cases reported the previous day.

    Narayana Health City’s Dr Nidhin Mohan from general medicine told Livemint, “New COVID-19 variants tend to spread more rapidly and may be less responsive to existing vaccines.”

    According to doctors, these new sub-variants are highly transmissible but have not shown signs of causing more severe illness than earlier strains. The similarity is that those with compromised health and kids are at risk.

    Dr Michelle Shah, Pediatric Lifestyle Medicine Specialist, pointed out, “These four sub-variants (LF.7, XFG, JN.1.16, and NB.1.8.1) are part of the evolution of the Omicron lineage. What we’re seeing is increased transmissibility. JN.1.16, a descendant of the widely circulating JN.1, has shown dominance in India. All these mutations are adept at immune escape, which is why reinfections occur, even in vaccinated individuals. However, vaccines continue to offer robust protection against severe disease and hospitalisation.”

    What to watch out for
    The new strain comes with mild symptoms– fever, continuous cough, loss of appetite or razor-blade sore throat.

    “By and large, symptoms are mild. Patients with fever, cough or red nose were particularly affected,” shared Dr Umang Agrawal, who handles infectious diseases at P. D. Hinduja Hospital & Medical Research Centre, Mahim, Mumbai.

    “Mild doesn’t mean negligible. People should watch for prolonged fatigue, chest discomfort, shortness of breath, or high-grade fever lasting more than 3 days. Also, if someone feels better and then worsens after a few days, that could be a sign of a secondary infection or post-viral inflammation. In children, elderly and immunocompromised, even low-grade symptoms warrant medical attention,” warns Shah.

    “Typical current symptoms are very similar to the common cold: sneezing, runny nose, sore throat, dry cough, and mild fever. Some also experience a persistent cough that interrupts sleep, fatigue, or shortness of breath or chest discomfort (which anyone with existing conditions should be concerned about). In some cases, COVID symptoms are not even respiratory symptoms at all: gastrointestinal symptoms or neurological symptoms. Rarely, there can be mild clotting issues,” explains Dr Raja Dhar, Director & HOD of Pulmonology at The Calcutta Medical Research Institute.

    Long-term effects remain unknown
    Despite mild symptoms, medical professionals warn that long-term effects are still not fully understood.

    “The concern around long COVID or post-COVID syndrome remains in the conversation, but it has certainly had lower proportions of the diseased assessed as milder. When we looked at the studies during the earlier Omicron waves, about 20 per cent of people reported long-term symptoms. However, that number has now decreased. Many will still experience some residual effects of fatigue, muscle pain, changes to mood, and changes to sleep, which are typical residual symptoms following many viral infections. While not completely absent, the risk of longer-term complications with these newer sub-variants appears to remain low,” Dhar noted.

    Who is at risk now?
    Since January, over 100 COVID-related deaths have been reported in India, mostly among those with pre-existing health conditions. This highlights the ongoing danger for the elderly and immunocompromised.

    “It’s a reminder that for vulnerable groups, COVID-19 is still very much a threat. Pre-existing conditions like heart disease, diabetes, and compromised immunity greatly increase the risk of complications, even from supposedly ‘mild’ variants. We need to ensure these individuals are prioritised for early treatment,” Shah observed, underscoring the risky attitude of those putting their guards down after the decline in COVID-19 cases.

    Kerala, Gujarat, Karnataka, and Delhi have seen more cases than other regions. Experts attribute this to factors like higher population density, increased testing, and more frequent travel.

    “All these states have almost always been among the first to witness a surge in COVID cases through all waves, including Omicron, primarily because of a high degree of intrastate and interstate movement, urban density, and travel, both domestic and international,” says Dhar.

    Advice for the public
    Doctors advise people should continue following basic precautions to protect themselves and others.

    During any surge in cases, one must be extra cautious, especially in public and crowded places.

    Annual COVID vaccination is necessary, particularly for high-risk groups. LiveMint

  • India’s healthcare sector is the one that hackers target the most in 2024

    India’s healthcare sector is the one that hackers target the most in 2024

    The Indian healthcare sector emerged as the most targeted industry for cyberattacks in 2024, accounting for 21.82% of total incidents, according to the latest India Cyber Threat Report 2025 released by Seqrite, the enterprise security arm of Quick Heal Technologies.

    The findings, compiled by researchers at Seqrite Labs—India’s largest malware analysis facility—highlight the growing vulnerabilities in healthcare institutions as they rapidly adopt digital technologies. With vast amounts of sensitive patient data and mission-critical systems, hospitals and healthcare providers have become key targets for ransomware groups and cybercriminals.

    The report identifies a sharp rise in ransomware attacks, phishing campaigns, and malware disguised as legitimate medical software. Sophisticated ransomware groups such as LockBit 3.0 and RansomHub were found targeting critical healthcare infrastructure, encrypting patient records and demanding ransom to restore access—posing a direct threat to patient care and operational continuity.

    In 2024, behaviour-based malware attacks accounted for 14.5% of all threats in healthcare. These threats are particularly dangerous because they mimic normal software behaviour to evade traditional security systems. Seqrite researchers found that cybercriminals increasingly exploited hospital networks, telemedicine platforms, and Internet of Medical Things (IoMT) devices.

    The report also notes that phishing campaigns impersonating health agencies and insurance companies successfully compromised 37% of healthcare staff. These campaigns use social engineering techniques to trick employees into revealing credentials or downloading malicious files.

    To address these evolving threats, Seqrite emphasized the need for robust, real-time security infrastructure. Its Endpoint Security (EPS) solution—recognized by AV-TEST for its corporate-grade performance—uses behaviour-based detection, cloud sandboxing, and automated rollback to combat ransomware attacks. For organizations using connected medical devices and cloud-based systems, Seqrite’s Extended Detection and Response (XDR) platform provides integrated monitoring across endpoints, networks, and cloud environments. The platform also supports AI-powered threat hunting, based on data collected from 8.44 million analyzed endpoints.

    In response to the growing use of generative AI, deepfakes, and cloud misconfigurations in cyberattacks, Seqrite has introduced new innovations, including the Seqrite Threat Intelligence Platform and the Seqrite Malware Analysis Platform (SMAP), to give enterprises better visibility and faster response capabilities.

    Calling the findings a wake-up call, Seqrite urged healthcare organizations to prioritize cybersecurity by adopting proactive and adaptive defenses. The report underscores the urgent need for the healthcare industry to build resilience against increasingly sophisticated cyber threats, which have now become a persistent risk to both data privacy and patient safety. Varindia

  • MedTech Europe urges for medical devices be free of tariffs

    MedTech Europe urges for medical devices be free of tariffs

    MedTech Europe has issued a statement calling on European policymakers to exempt medical technologies from any trade tariffs or export restrictions.

    In response to the European Commission’s (EC) conclusion of a public consultation on proposed EU countermeasures impacting trade with the US, MedTech Europe expressed deep concern over a draft package that “targets a broad range of finished medical devices, in vitro diagnostic (IVD) medical devices, and a variety of essential components used in their manufacture”.

    The trade body’s overall request was that medical technologies be included and prioritised in a “zero for zero” tariff agreement on industrial goods or as part of any negotiated settlement that seeks to eliminate tariffs on both sides of the Atlantic.

    The EC’s consultation, which was announced on 8 May and closed on 10 June, was launched to gather input towards finalising proposals for the adoption of countermeasures against the Trump’s administration’s imposition of tariffs on the bloc.

    Upon launching the consultation, EC president Ursula von der Leyen said: “Tariffs are already having a negative impact on the global economies. The EU remains fully committed to finding negotiated outcomes with the US.

    “At the same time, we continue preparing for all possibilities, and the consultation launched today will help guide us in this necessary work.”

    President Trump’s initial announcement of tariffs for many countries and regions worldwide on 2 April has been marked by continued flip-flopping. The EU was originally facing 20% blanket tariffs on all imported goods from 9 April; however, the White House walked back its plans on the date, instead choosing to enact a 90-day pause on the imposition of tariffs.

    Trump has since threatened to raise tariffs on the EU to 50% if no deal is reached by the end of the pause period on 9 July.

    According to reports by German newspaper Handelsblatt, the EU was willing to accept a flat fee of 10% tariffs. However, in a statement shared with Reuters, the EC dismissed the claims, stating: “Negotiations are ongoing, and no agreement has been reached at this stage. The EU has from the start objected to unjustified and illegal US tariffs.”

    In concluding remarks, MedTech Europe stated: “Patients must not become collateral damage in a trade dispute. Safeguarding their access to the technologies they depend on must remain a shared priority.”

    On 11 June, leading players from the medtech industry convened on Capitol Hill alongside the Advanced Medical Technology Association (AdvaMed) to advocate for the elimination of tariffs on medical technologies.

    After the Trump administration’s announcement of a 90-day pause on the imposition of tariffs for most countries, barring China, AdvaMed CEO Scott Whitaker voiced similar hopes as MedTech Europe, restating his previous request that a ‘zero for zero’ tariff deal on medtech with all of the US’s key trading partners be struck. GlobalData

  • India boosts surveillance & genetic sequencing amid the Covid pandemic

    India boosts surveillance & genetic sequencing amid the Covid pandemic

    Cases of Covid-19 have never fallen to zero in India since the coronavirus disease was first detected, Naveen Kumar, Director, National Institute of Virology (NIV), Pune, said on Wednesday (June 18, 2025), adding, “We have now scaled-up surveillance and genome sequencing following the recent surge in cases.”

    The NIV was continuously monitoring the evolution of the SARS-CoV-2 coronavirus by whole genome sequencing of RT-PCR (reverse transcriptase polymerase chain reaction) positive samples referred from 73 virus research and diagnostic laboratories across the country, Dr Kumar said.

    The recent upsurge in Covid-19 cases had been noticed since the second week of April 2025, Dr. Kumar said, adding that genomic analysis had revealed the surge was due to the JN.1.16 sub-lineage of the Omicron variant, and that since May 2025, it had been replaced by the XFG (LF.7 and LP.81.2) recombinant variant. Whole genome sequences have been submitted to the Indian Biological Data Centre and GISAID (Global Initiative on Sharing All Influenza Data).

    The virus isolation of the newer variants would be helpful in assessing vaccine effectiveness, and in supporting India’s indigenous efforts for vaccine development, Dr Kumar said.

    “Currently, two monovalent Omicron-based vaccines are available (Biological E Limited’s Corbivax, and Serum Institute of India’s COVOVAX). The situation is being continuously monitored by the Union Health Ministry,” the head of the NIV said.

    India reported its first cases of Covid-19 on January 30, 2020 in three towns of Kerala, in three Indian medical students who had returned from Wuhan, the epicentre of the pandemic.

    India’s active Covid-19 caseload dropped marginally to 6,483 on Wednesday from 6,836 the previous day, according to latest data from the Ministry of Health. Four deaths have been recorded in the past 24 hours.

    Of the four deaths, two were reported in Maharashtra, while Kerala and Delhi reported one each, respectively. All four individuals were elderly, and had existing respiratory ailments and other chronic conditions.

    India is currently witnessing a rise in infections driven by emerging subvariants, including LF.7, XFG, JN.1, and the newly detected NB.1.8.1.

    Delhi recorded the highest number of fresh Covid-19 cases, with 65 new infections taking its total to 620. Kerala continues to report the highest number of active Covid-19 cases at 1,384, followed by Gujarat with 1,105. Karnataka and Maharashtra reported 653 and 489 active cases, respectively.

    Covid-19 is the symptomatic disease caused by the SARS-CoV-2 coronavirus. Vaccination remains an important public health countermeasure against Covid-19, the World Health Organization (WHO) has said. SARS-CoV-2 continues to undergo sustained evolution since its emergence in humans, with important genetic and antigenic changes in the spike protein, the global health body said. The Hindu